Clinical Trial Update: The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal Women [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of extended-release oxybutynin chloride on vasomotor symptoms in healthy postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hot Flashes
• Menopause

Drugs mentioned

• Ditropan XL (oxybutynin chloride)

Snippet

Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC | Conditions: Menopause, Hot Flashes | Phase 2 | Status: COMPLETED